Literature DB >> 21747385

Streamlining biomarker discovery.

Martin Latterich, Jan E Schnitzer.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21747385     DOI: 10.1038/nbt.1917

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

Review 1.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.

Authors:  Andrea D Weston; Leroy Hood
Journal:  J Proteome Res       Date:  2004 Mar-Apr       Impact factor: 4.466

2.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.

Authors:  Wells W Wu; Guanghui Wang; Seung Joon Baek; Rong-Fong Shen
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

3.  Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification.

Authors:  Jacob D Jaffe; Hasmik Keshishian; Betty Chang; Theresa A Addona; Michael A Gillette; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2008-06-04       Impact factor: 5.911

Review 4.  Proteomic biomarker discovery: it's more than just mass spectrometry.

Authors:  Josip Blonder; Haleem J Issaq; Timothy D Veenstra
Journal:  Electrophoresis       Date:  2011-05-09       Impact factor: 3.535

Review 5.  Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.

Authors:  Sandipan Ray; Panga J Reddy; Rekha Jain; Kishore Gollapalli; Aliasgar Moiyadi; Sanjeeva Srivastava
Journal:  Proteomics       Date:  2011-05-04       Impact factor: 3.984

6.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

Authors:  Terri A Addona; Xu Shi; Hasmik Keshishian; D R Mani; Michael Burgess; Michael A Gillette; Karl R Clauser; Dongxiao Shen; Gregory D Lewis; Laurie A Farrell; Michael A Fifer; Marc S Sabatine; Robert E Gerszten; Steven A Carr
Journal:  Nat Biotechnol       Date:  2011-06-19       Impact factor: 54.908

7.  Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?

Authors:  James W Denham; Allison Steigler; Chantelle Wilcox; David S Lamb; David Joseph; Chris Atkinson; Keen-Hun Tai; Nigel A Spry; Paul S Gleeson; Catherine D'Este
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

8.  Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.

Authors:  Cloud P Paweletz; Matthew C Wiener; Andrey Y Bondarenko; Nathan A Yates; Qinghua Song; Andy Liaw; Anita Y H Lee; Brandon T Hunt; Ernst S Henle; Fanyu Meng; Holly Funk Sleph; Marie Holahan; Sethu Sankaranarayanan; Adam J Simon; Robert E Settlage; Jeffrey R Sachs; Mark Shearman; Alan B Sachs; Jacquelynn J Cook; Ronald C Hendrickson
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

9.  Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.

Authors:  Shao-En Ong; Blagoy Blagoev; Irina Kratchmarova; Dan Bach Kristensen; Hanno Steen; Akhilesh Pandey; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2002-05       Impact factor: 5.911

Review 10.  Proteomics: new technologies and clinical applications.

Authors:  Martin Latterich; Mark Abramovitz; Brian Leyland-Jones
Journal:  Eur J Cancer       Date:  2008-11-01       Impact factor: 9.162

View more
  5 in total

1.  New astroglial injury-defined biomarkers for neurotrauma assessment.

Authors:  Julia Halford; Sean Shen; Kyohei Itamura; Jaclynn Levine; Albert C Chong; Gregg Czerwieniec; Thomas C Glenn; David A Hovda; Paul Vespa; Ross Bullock; W Dalton Dietrich; Stefania Mondello; Joseph A Loo; Ina-Beate Wanner
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

Review 2.  Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

Authors:  Carol Chase Huizar; Itay Raphael; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2020-09-20       Impact factor: 4.868

3.  Clinical proteomics and OMICS clues useful in translational medicine research.

Authors:  Elena López; Luis Madero; Juan López-Pascual; Martin Latterich
Journal:  Proteome Sci       Date:  2012-05-29       Impact factor: 2.480

4.  On protein abundance distributions in complex mixtures.

Authors:  Ja Koziol; Nm Griffin; F Long; Y Li; M Latterich; Je Schnitzer
Journal:  Proteome Sci       Date:  2013-01-29       Impact factor: 2.480

Review 5.  Mass spectrometric protein maps for biomarker discovery and clinical research.

Authors:  Yansheng Liu; Ruth Hüttenhain; Ben Collins; Ruedi Aebersold
Journal:  Expert Rev Mol Diagn       Date:  2013-10-21       Impact factor: 5.225

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.